2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one

C168H184F12N24O17 — CID 167597745

About 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one

2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one (PubChem CID 167597745) has the molecular formula C168H184F12N24O17 and a molecular weight of 3039.45 g/mol. Its IUPAC name is 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one.

Molecular Properties

• Compound Name: 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one
• PubChem CID: 167597745
• Molecular Formula: C168H184F12N24O17
• Molecular Weight: 3039.45 g/mol
• Exact Mass: 3037.41
• IUPAC Name: 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one
• SMILES: C=Cc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)N3[C@H](C(=O)Cc4nc(C(F)(F)F)ccc4C)CC4(CCC(=O)C[C@@H](C)CCC=C(C)C)C[C@@H]34)c12.C=Cc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)O)c12.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)/C=C/CC[C@H](C)CC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCC[C@H](C)CC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(C)=CCC[C@H](C)CC(=O)CC[C@@]12C[C@@H](C(=O)Cc3nc(C(F)(F)F)ccc3C)N[C@@H]1C2
• InChI: InChI=1S/C44H49F3N6O4.C40H43F3N6O4.C40H41F3N6O4.C26H35F3N2O2.C18H16N4O3/c1-8-30-17-31(32-22-48-29(7)49-23-32)18-34-41(28(6)54)51-52(42(30)34)24-40(57)53-36(37(56)19-35-27(5)12-13-38(50-35)44(45,46)47)20-43(21-39(43)53)15-14-33(55)16-26(4)11-9-10-25(2)3;2*1-22-7-5-6-8-26-14-27(28-19-44-25(4)45-20-28)15-30-37(24(3)50)47-48(38(26)30)21-36(53)49-32(17-39(18-35(39)49)12-11-29(51)13-22)33(52)16-31-23(2)9-10-34(46-31)40(41,42)43;1-16(2)6-5-7-17(3)12-19(32)10-11-25-14-21(31-24(25)15-25)22(33)13-20-18(4)8-9-23(30-20)26(27,28)29;1-4-12-5-13(14-7-19-11(3)20-8-14)6-15-17(10(2)23)21-22(18(12)15)9-16(24)25/h8,10,12-13,17-18,22-23,26,36,39H,1,9,11,14-16,19-21,24H2,2-7H3;9-10,14-15,19-20,22,32,35H,5-8,11-13,16-18,21H2,1-4H3;6,8-10,14-15,19-20,22,32,35H,5,7,11-13,16-18,21H2,1-4H3;6,8-9,17,21,24,31H,5,7,10-15H2,1-4H3;4-8H,1,9H2,2-3H3,(H,24,25)/b;;8-6+;;/t26-,36-,39+,43?;2*22-,32-,35+,39-;17-,21-,24+,25-;/m0000./s1
• InChIKey: JHTBVKVFYIWHPR-PHTUBIDISA-N
• XLogP: 31.24
• TPSA: 541.06 Ų
• H-Bond Donors: 2
• H-Bond Acceptors: 37
• Rotatable Bonds: 42
• Heavy Atoms: 221
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3039.45
LogP ≤ 5	31.24
H-Bond Donors ≤ 5	2
H-Bond Acceptors ≤ 10	37

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one?

The IUPAC name of 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one (CID 167597745) is 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one.

What is the SMILES notation for 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one?

The canonical SMILES for 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one is C=Cc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)N3[C@H](C(=O)Cc4nc(C(F)(F)F)ccc4C)CC4(CCC(=O)C[C@@H](C)CCC=C(C)C)C[C@@H]34)c12.C=Cc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)O)c12.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)/C=C/CC[C@H](C)CC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCC[C@H](C)CC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(C)=CCC[C@H](C)CC(=O)CC[C@@]12C[C@@H](C(=O)Cc3nc(C(F)(F)F)ccc3C)N[C@@H]1C2.

What is the InChIKey of 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one?

The InChIKey is JHTBVKVFYIWHPR-PHTUBIDISA-N. The full InChI is InChI=1S/C44H49F3N6O4.C40H43F3N6O4.C40H41F3N6O4.C26H35F3N2O2.C18H16N4O3/c1-8-30-17-31(32-22-48-29(7)49-23-32)18-34-41(28(6)54)51-52(42(30)34)24-40(57)53-36(37(56)19-35-27(5)12-13-38(50-35)44(45,46)47)20-43(21-39(43)53)15-14-33(55)16-26(4)11-9-10-25(2)3;2*1-22-7-5-6-8-26-14-27(28-19-44-25(4)45-20-28)15-30-37(24(3)50)47-48(38(26)30)21-36(53)49-32(17-39(18-35(39)49)12-11-29(51)13-22)33(52)16-31-23(2)9-10-34(46-31)40(41,42)43;1-16(2)6-5-7-17(3)12-19(32)10-11-25-14-21(31-24(25)15-25)22(33)13-20-18(4)8-9-23(30-20)26(27,28)29;1-4-12-5-13(14-7-19-11(3)20-8-14)6-15-17(10(2)23)21-22(18(12)15)9-16(24)25/h8,10,12-13,17-18,22-23,26,36,39H,1,9,11,14-16,19-21,24H2,2-7H3;9-10,14-15,19-20,22,32,35H,5-8,11-13,16-18,21H2,1-4H3;6,8-10,14-15,19-20,22,32,35H,5,7,11-13,16-18,21H2,1-4H3;6,8-9,17,21,24,31H,5,7,10-15H2,1-4H3;4-8H,1,9H2,2-3H3,(H,24,25)/b;;8-6+;;/t26-,36-,39+,43?;2*22-,32-,35+,39-;17-,21-,24+,25-;/m0000./s1.

What are the key properties of 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one?

2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one has a molecular weight of 3039.45 g/mol, XLogP of 31.24, 42 rotatable bonds, 2 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetic acid;(5S)-1-[(1R,3S)-2-[2-[3-acetyl-7-ethenyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]-5,9-dimethyldec-8-en-3-one;(1R,6S,9E,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-4,20-dione;(1R,6S,22R,25S)-16-acetyl-6-methyl-13-(2-methylpyrimidin-5-yl)-25-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;(5S)-5,9-dimethyl-1-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-5-yl]dec-8-en-3-one is sourced from PubChem (CID 167597745), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).